Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Rankning i aktier #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Aktiekurs
$0.2488447
Senast synkroniserad: 2024-10-01
Marknadsvärde
$2.01M
Förändring (1 dag)
-1.88%
Förändring (1 år)
0.00%
Land
IN
Handel Ortin Laboratories Limited (ORTINLAB)

Kategori

Intäkter för Ortin Laboratories Limited (ORTINLAB)
Intäkter i Jun 2024 TTM: $89.95K
Enligt Ortin Laboratories Limited senaste finansiella rapporter är företagets nuvarande intäkter (TTM) $89.95K. År 2023 hade företaget intäkter på $732.57K en minskning jämfört med intäkterna år 2022, som var $1.08M. Intäkter är det totala belopp som ett företag genererar från försäljning av varor eller tjänster. Till skillnad från vinst dras inga kostnader av.
Intäkts­historik för Ortin Laboratories Limited från 2008 till 2026
Intäkter vid slutet av varje år
År Intäkter Ändra
2026 (TTM) $89.95K -64.48%
2024 $253.23K -65.43%
2023 $732.57K -32.44%
2022 $1.08M -2.82%
2021 $1.12M -95.72%
2020 $26.04M 10.75%
2019 $23.51M 92.06%
2018 $12.24M 87.73%
2017 $6.52M 8.62%
2016 $6.00M -4.55%
2015 $6.29M -33.47%
2014 $9.45M -12.98%
2013 $10.86M -35.79%
2012 $16.92M 20.37%
2011 $14.06M 101.43%
2010 $6.98M 19.15%
2009 $5.86M -19.40%
2008 $7.27M 0.00%
Intäkter för liknande företag eller konkurrenter